Progress Meter


Our Goal: $1,000,000
Currently: $1,614.20
Updated: 01/22/2010
Making GREAT STRIDES--Exciting Research News!
News from CF - Latest News from CF
Saturday, 12 April 2008 21:49
Dear Friend,

We have exciting news! Last week, we announced promising results from an early Phase 2 study of VX-770, an oral compound developed in collaboration with Vertex Pharmaceuticals that targets a basic defect in cystic fibrosis.

This is the first time that any potential therapy has improved the abnormal sweat chloride (salt) levels in a person with CF.

We are very pleased with these results, but much more work remains to be done to ensure a brighter future for people with CF. Your support is crucial for us to make further progress.
Last Updated ( Saturday, 26 April 2008 17:18 )
 

Like it? Share it!